Lynch Samuel Eugene 4
4 · BIOMIMETIC THERAPEUTICS, INC. · Filed Mar 30, 2012
Insider Transaction Report
Form 4
Lynch Samuel Eugene
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2012-03-30$2.40/sh+20,000$48,000→ 1,239,391 total - Purchase
Common Stock
2012-03-29$2.38/sh+30,638$72,891→ 1,200,029 total - Purchase
Common Stock
2012-03-30$2.46/sh+19,362$47,632→ 1,219,391 total
Holdings
- 5,550(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]This price represents the weighted average purchase price of multiple transactions on the reported date at prices that ranged between $2.33 and $2.40. Detailed information regarding the number of shares purchased at each separate price will be provided upon request by the Commission staff, the issuer or a security holder of the issuer.
- [F2]This price represents the weighted average purchase price of multiple transactions on the reported date at prices that ranged between $2.42 and $2.49. Detailed information regarding the number of shares purchased at each separate price will be provided upon request by the Commission staff, the issuer or a security holder of the issuer.
- [F3]Dr. Lynch disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.